Ryan Fischesser, VP of Finance and Controller at Caribou Biosciences, Inc. (CRBU), bought 7,387 shares at $4.11 ($30K) on 2022-01-11, disclosed to the SEC on 2022-01-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.69 | 569 | $2K | 5.2% |
| 2 | $4.11 | 6,818 | $28K | 94.8% |
| Total | $4.00 avg | 7,387 | $30K | 100% |
| Filing → |
| CRBU | BUY | 2021-10-12 | $5K | — | Filing → |